open-burger-menu
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
📈 NEW Report: Abortions, Tax Funding UP at Planned Parenthood >>
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

close-panel
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Research Type:

Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research

Sort 1464 results by:

Filter results further
Filter Applied. Clear All

Latest Posts

October 6, 2026 A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Inside The Government Decision That Opened Up Abortion Pill Floodgates Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Research Type
Publication Type
By State
See All
By Author
See All
Reset All Filters

Did You Know ?

Did You Know ?

In the fourth week, the embryonic heart starts beating. The neural tube, which becomes the brain and spinal cord, forms. At this point, a woman has likely only been aware of her pregnancy for one week.

Did You Know ?

In the seventh week after conception, networks of neurons produce brain waves that have been recorded as early as 6 ½ weeks after conception. The embryo spontaneously moves his arms, hands, and legs, and may even hiccup. The embryo’s heart now has all four chambers.

Did You Know ?

By the seventeenth and eighteenth week after gestation, the fetus shows a clear response to pain in multiple studies, and at least one brain pathway is mature enough to create a perception of pain. The fetus also practices breathing, crying, and breastfeeding in the womb. The fetal heart has beat over 20 million times and circulates about 55 quarts of blood per day.

Did You Know ?

In the eighth month of pregnancy the fetal brain is ready to learn! At 32 weeks after conception, neurons are creating 40,000 new connections, called synapses, every second! With repeated exposures, the fetus can learn flavors, nursery rhymes, songs, and even words that she will recognize after birth!

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review
Latest Research / Life & the Law

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review

This paper critically analyzes the FDA's 2021 REMS Review leading to the removal of the in-person dispensing requirement for mifepristone.

Zachary Sluzala,… Ingrid Skop,…
October 6, 2026
Inside The Government Decision That Opened Up Abortion Pill Floodgates
Latest Research / Abortion Drugs

Inside The Government Decision That Opened Up Abortion Pill Floodgates

The decision "fell well short" of the FDA's standards.

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026
Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Latest Research / Life & the Law

Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

This paper critically analyzes the FDA's 2021 literature review that served as the basis for its controversial decision to remove…

Ingrid Skop,…
October 6, 2026
Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement
Latest Research / General

Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement

A new peer-reviewed article on the Food and Drug Administration’s (FDA) 2021 complete review of mifepristone’s Risk Evaluation and Mitigation…

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026
Abortion Reporting: Kentucky (2025)
Latest Research / Maternal & Public Health

Abortion Reporting: Kentucky (2025)

In 2025, five brick-and-mortar abortions were reported in Kentucky by the state’s Cabinet for Health and Family Services. The data…

Elyse Gaitan Mia Steupert,…
October 5, 2026
Life & the Law

Filed: CLI and ACLJ Amicus Brief in SisterSong v. Georgia

After litigation in lower courts, the constitutionality of Georgia's 2019 LIFE Act, which protects fetal life from the moment of a detectable heartbeat, is now being considered before the Supreme Court of Georgia. The Charlotte Lozier Institute and the American Center for Law & Justice have submitted an amicus brief arguing that Georgia has a compelling interest in protecting fetal life before viability due to the evidence for the presence of fetal pain early in pregnancy.

charlotte-lozier-institute Charlotte Lozier Institute
January 13, 2025
Maternal & Public Health

Abortion Reporting: Arizona (2023)

In 2023, there were 12,888 abortions reported in Arizona, an increase of 12% from 2022. Abortions performed on Arizona residents increased by 11%, while drug-induced abortions increased by 15%.

Mia Steupert, M.A. Elyse Gaitan
January 10, 2025
Maternal & Public Health

Abortion Reporting: Kansas (2023)

There were 19,467 abortions reported in Kansas in 2023 (19,466 reported in-state occurrences, and one reported out-of-state occurrence), a steep increase of 58% from 2022 and a 148% increase from 2021 to 2023.

Mia Steupert, M.A. Elyse Gaitan
January 9, 2025
Maternal & Public Health

Abortion Reporting: Virginia (2022)

In 2022, there were 16,722 abortions reported in Virginia, up 4% from the previous year.

Mia Steupert, M.A. Elyse Gaitan
January 9, 2025
Maternal & Public Health

Abortion Reporting: Utah (2023)

Utah reported 4,080 abortions in 2023, up 7% from the previous year when 3,824 abortions occurred in Utah.

Mia Steupert, M.A. Elyse Gaitan
January 9, 2025
Maternal & Public Health

Abortion Reporting: Tennessee (2022)

According to the CDC, there were 6,452 abortions performed in Tennessee in 2022, a decrease of 47% from the previous year and the lowest total ever reported by Tennessee since CLI started tracking Tennessee’s abortion data from 2008.

Mia Steupert, M.A. Elyse Gaitan
January 8, 2025
Maternal & Public Health

Abortion Reporting: District of Columbia (2022)

According to this data, there were 4,023 abortions in 2022, an increase of 4% from 2021. Drug-induced abortions decreased by 0.4% from 1,994 in 2021 to 1,987 in 2022.

Mia Steupert, M.A. Elyse Gaitan
January 8, 2025
Maternal & Public Health

Abortion Reporting: Washington (2022)

According to the CDC, 20,193 abortions were performed in Washington in 2022, an increase of 24% from 2021.

Mia Steupert, M.A. Elyse Gaitan
January 8, 2025

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image